Cooperative Centers for Translational Research in Human Immunology

The long-term goal of the Cooperative Centers for Translational Research on Human Immunology and Biodefense (CCHI) program is the translation of research into clinical applications in humans. The immediate goals are to support basic and translational research on human immunological responses to NIAID Category A, B or C priority pathogens, their toxins, or other emerging or re-emerging infectious diseases; and to maintain the stable, flexible, and centralized infrastructure needed to promote and coordinate multi-disciplinary research in human immunology as it relates to defense against these agents. The CCHI program was established in 2003 by the NIAID Division of Allergy, Immunology and Transplantation as part of the overall NIAID biodefense effort. The renewal of this program maintains NIAID’s commitment in this effort through continuing support for cooperative immunology centers focused on the translation of research from animals to humans.

Participating Centers

View NIAID CCHIs in a larger map

Baylor Research Institute
Dallas, TX 75204
Emory University Vaccine Center
Decatur, GA 30033
Massachusetts General Hospital
Boston, MA, 02199
Oklahoma Medical Research Foundation
Oklahoma City, OK 73104
Stanford University
Palo Alto, CA 94304
University of Rhode Island
Providence, RI 02903
University of Massachusetts Medical School
Worcester, MA 01605
University of Maryland School of Medicine
Baltimore, MD 21201

News / Events

Services provided by the Baylor core facility are now detailed under the SERVICES menu.

The CCHI Genomics Portal is under development. It should be available for public beta in June '10.

The CCHI web site is now available. Check back for updates.